An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation
- PMID: 10510089
- PMCID: PMC2195650
- DOI: 10.1084/jem.190.7.995
An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation
Abstract
A T helper cell type 1-mediated colitis develops in severe combined immunodeficient mice after transfer of CD45RB(high) CD4(+) T cells and can be prevented by cotransfer of the CD45RB(low) subset. The immune-suppressive activities of the CD45RB(low) T cell population can be reversed in vivo by administration of an anti-transforming growth factor beta antibody. Here we show that interleukin (IL)-10 is an essential mediator of the regulatory functions of the CD45RB(low) population. This population isolated from IL-10-deficient (IL-10(-/-)) mice was unable to protect from colitis and when transferred alone to immune-deficient recipients induced colitis. Treatment with an anti-murine IL-10 receptor monoclonal antibody abrogated inhibition of colitis mediated by wild-type (WT) CD45RB(low) CD4(+) cells, suggesting that IL-10 was necessary for the effector function of the regulatory T cell population. Inhibition of colitis by WT regulatory T cells was not dependent on IL-10 production by progeny of the CD45RB(high) CD4(+) cells, as CD45RB(low) CD4(+) cells from WT mice were able to inhibit colitis induced by IL-10(-/-) CD45RB(high) CD4(+) cells. These findings provide the first clear evidence that IL-10 plays a nonredundant role in the functioning of regulatory T cells that control inflammatory responses towards intestinal antigens.
Figures



Similar articles
-
A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells.J Exp Med. 1996 Jun 1;183(6):2669-74. doi: 10.1084/jem.183.6.2669. J Exp Med. 1996. PMID: 8676088 Free PMC article.
-
Colitogenic Th1 cells are present in the antigen-experienced T cell pool in normal mice: control by CD4+ regulatory T cells and IL-10.J Immunol. 2003 Jul 15;171(2):971-8. doi: 10.4049/jimmunol.171.2.971. J Immunol. 2003. PMID: 12847269
-
B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.J Immunol. 2001 Aug 1;167(3):1830-8. doi: 10.4049/jimmunol.167.3.1830. J Immunol. 2001. PMID: 11466409
-
Control of experimental inflammatory bowel disease by regulatory T cells.Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 2):S185-9. doi: 10.1164/ajrccm.162.supplement_3.15tac9. Am J Respir Crit Care Med. 2000. PMID: 11029392 Review.
-
Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation.Immunol Today. 1997 Feb;18(2):61-4. doi: 10.1016/s0167-5699(97)01000-1. Immunol Today. 1997. PMID: 9057354 Review.
Cited by
-
TLR2 and Nod2 mediate resistance or susceptibility to fatal intracellular Ehrlichia infection in murine models of ehrlichiosis.PLoS One. 2013;8(3):e58514. doi: 10.1371/journal.pone.0058514. Epub 2013 Mar 19. PLoS One. 2013. PMID: 23526993 Free PMC article.
-
Cytosolic HMGB1 controls the cellular autophagy/apoptosis checkpoint during inflammation.J Clin Invest. 2015 Mar 2;125(3):1098-110. doi: 10.1172/JCI76344. Epub 2015 Feb 2. J Clin Invest. 2015. PMID: 25642769 Free PMC article.
-
CD4⁺T cells: differentiation and functions.Clin Dev Immunol. 2012;2012:925135. doi: 10.1155/2012/925135. Epub 2012 Mar 14. Clin Dev Immunol. 2012. PMID: 22474485 Free PMC article. Review.
-
Regulatory T cells in the immunodiagnosis and outcome of kidney allograft rejection.Clin Dev Immunol. 2013;2013:852395. doi: 10.1155/2013/852395. Epub 2013 Jun 15. Clin Dev Immunol. 2013. PMID: 23843861 Free PMC article. Review.
-
B7-1/B7-2 blockade overrides the activation of protective CD8 T cells stimulated in the absence of Foxp3+ regulatory T cells.J Leukoc Biol. 2013 Aug;94(2):367-76. doi: 10.1189/jlb.0313118. Epub 2013 Jun 6. J Leukoc Biol. 2013. PMID: 23744647 Free PMC article.
References
-
- Elson C.O., Sartor R.B., Tennyson G.S., Riddell R.H. Experimental models of inflammatory bowel disease. Gastroenterology. 1995;109:1344–1367. - PubMed
-
- Powrie F., Leach M.W. Genetic and spontaneous models of inflammatory bowel disease in rodentsevidence for abnormalities in mucosal immune regulation. Ther. Immunol. 1995;2:115–123. - PubMed
-
- Morrissey P.J., Charrier K., Braddy S., Liggitt D., Watson J.D. CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells. J. Exp. Med. 1993;178:237–244. - PMC - PubMed
-
- Powrie F., Leach M.W., Mauze S., Caddle L.B., Coffman R.L. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C.B-17 scid mice. Int. Immunol. 1993;5:1461–1471. - PubMed
-
- Powrie F., Leach M.W., Mauze S., Menon S., Caddle L.B., Coffman R.L. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity. 1994;1:553–562. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials